Private Equity
Wayne, Pennsylvania-based Vesper Medical Inc, a developer of medical devices for minimally invasive peripheral vascular procedures, has secured $37 million in financing. Vensana Capital and Gilde led the round with participation from New Enterprise Associates and Quaker Partners.
1 min read · 29 May 2019
Wayne, Pennsylvania-based Vesper Medical Inc, a developer of medical devices for minimally invasive peripheral vascular procedures, has secured $37 million in financing. Vensana Capital and Gilde led the round with participation from New Enterprise Associates and Quaker Partners.
1 min read · 29 May 2019
1 min read · 29 May 2019
Finistere Ventures, OurCrowd, Tnuva and Tempo Beverages are creating a consortium that will invest up to $100 million in agrifood startups. The partnership was created following the Israeli government's establishment of a foodtech-focused incubator in Northern Israel.
5 min read · 28 May 2019
Finistere Ventures, OurCrowd, Tnuva and Tempo Beverages are creating a consortium that will invest up to $100 million in agrifood startups. The partnership was created following the Israeli government's establishment of a foodtech-focused incubator in Northern Israel.
5 min read · 28 May 2019
Pilot Growth Management LLC has raised $45 million for its second growth equity fund. With offices in Francisco, New York, and Washington, DC, Pilot Growth is a technology growth equity firm.
3 min read · 28 May 2019
Panacea Venture has closed its inaugural healthcare fund at $180.5 million, beating its $150 million target. Panacea Venture Healthcare Fund I's backers include endowments, foundations, sovereign wealth funds, pension programs, consultants, fund-of-funds, asset managers and family offices. Atlantic-Pacific Capital was the placement agent.
3 min read · 28 May 2019
Future Positive Capital has raised $57.1 million for its new fund. The initial target was $55 million. The backers include Bpifrance, Draper Esprit, the European Investment Fund and Isomer Capital. The Paris and London-based firm "backs companies that use advances in artificial intelligence, synthetic biology, genetics, and other deep technologies to solve the world's most pressing challenges such as sustainably feeding the world’s growing population, combating climate change and serving the ageing population."
6 min read · 28 May 2019
2 min read · 28 May 2019
6 min read · 27 May 2019
